RT Journal Article
SR Electronic
T1 Prevalence and associations of COVID-19 testing in an online sample of transgender and non-binary individuals
JF BMJ Global Health
JO BMJ Global Health
FD BMJ Publishing Group Ltd
SP e006808
DO 10.1136/bmjgh-2021-006808
VO 6
IS 9
A1 Arjee Restar
A1 Henri M Garrison-Desany
A1 Kellan E Baker
A1 Tyler Adamson
A1 Sean Howell
A1 Stefan David Baral
A1 Don Operario
A1 S Wilson Beckham
YR 2021
UL http://gh.bmj.com/content/6/9/e006808.abstract
AB Background Testing for COVID-19 and linkage to services is fundamental to successful containment and control of transmission. Yet, knowledge on COVID-19 testing among transgender and non-binary communities remains limited.Methods Between October 2020 and November 2020, we examined the prevalence and associations of COVID-19 testing in an online sample of transgender and non-binary people (n=536). Multivariable hierarchical logistic regression analyses examined associations between COVID-19 testing and participants’ sociodemographic, mental health, substance use, gender affirmation, economic changes and healthcare experiences.Results Prevalence of COVID-19 testing in this sample was 35.5% (n=190/536). In the final model, transgender and non-binary participants from upper socioeconomic income background and Europe, who reported having active alcohol use disorder, limited access to gender-affirming surgery, had more than 20% reduction in income, and experienced mistreatment in a health facility due to gender identity had significantly increased odds of COVID-19 testing (all p<0.05); those who reported recent tobacco use had significantly lower odds of COVID-19 testing (p=0.007).Conclusions These findings highlight structural disparities in COVID-19 testing and reinforce the importance of increasing testing strategies for transgender and non-binary populations.No data are available.